Showing results (331-340 of 383) with videos related to

Sort By:
Pageof 39
Cell Reports|May 13, 2017
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 ExpressionAngel Garcia-Diaz, Daniel Sanghoon Shin, Blanca Homet Moreno, et al.
The Lancet. Oncology|June 22, 2014
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trialSusan J Dutton, David R Ferry, Jane M Blazeby, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 15, 2018
Diminished Cortical Thickness Is Associated with Impulsive Choice in AdolescenceMarieta Pehlivanova, Daniel H Wolf, Aristeidis Sotiras, et al.
Scientific Reports|August 30, 2020
Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumabMaria Inmaculada Dominguez-Mozo, Silvia Perez-Perez, Luisa María Villar, et al.
International Journal of Radiation Oncology, Biology, Physics|December 7, 2019
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung CancerJohn D Fenwick, David B Landau, Angela T Baker, et al.
JAMA Oncology|June 2, 2022
Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the monarchE Randomized Clinical TrialMiguel Martin, Roberto Hegg, Sung-Bae Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2017
Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal CancerRussell D Petty, Asa Dahle-Smith, David A J Stevenson, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 23, 2012
The EMT signaling pathways in endometrial carcinomaEva Colas, Nuria Pedrola, Laura Devis, et al.
Rural and Remote Health|September 25, 2023
Massive testing in the Galapagos Islands and low positivity rate to control SARS-CoV-2 spread during the first semester of the COVID-19 pandemic: a story of success for Ecuador and South AmericaAlexander Paolo Vallejo-Janeta, Diana Morales-Jadan, Alberto Velez, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2016
IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung CancerDavid B Landau, Laura Hughes, Angela Baker, et al.
Pageof 39